A Prospective Study Comparing Ranibizumab Plus Dexamethasone Combination Therapy Versus Ranibizumab Monotherapy for Wet AMD

Clinical trial NCT00793923 · COMPLETED

Trial details

NCT number: NCT00793923
Sponsor: Subhransu K. Ray, M.D., Ph.D.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Exudative Age-Related Macular Degeneration

Start date: 2008-01-01
Primary completion: 2012-01-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.